Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
BioCardia Q1 2026 Earnings Call - Japan PMDA Clears Path for Shonin Approval on CardiAMP
BioCardia delivered a quarter defined by regulatory momentum rather than revenue, advancing its CardiAMP cell therapy for ischemic heart failure toward a pivotal regulatory decision in Japan. The comp...
- Japan’s PMDA has formally indicated it will accept BioCardia’s blinded echocardiography data as the basis for a Shonin pre-market application for CardiAMP, potentially bypassing the need for additional Phase 3 trials in Japan.
- The FDA’s Q-Sub meeting confirmed that a pre-market approval (PMA) is the appropriate pathway for U.S. approval of CardiAMP for ischemic heart failure, and the agency encouraged BioCardia to complete the ongoing CardiAMP HF II trial to support the application.
- Blinded echocardiography data from the CardiAMP Heart Failure Trial showed that treated patients did not experience the negative cardiac remodeling (increased heart volumes) seen in control subjects, with statistically significant benefits in a subgroup with elevated biomarkers.
- +7 more takeaways
Banzai Q1 2026 Earnings Call - Debt Paydown and ConnectAndSell Acquisition Anchor Growth Strategy
Banzai reported a flat run-rate revenue of $2.7 million for Q1 2026, down 20% year-over-year due to a one-time CreateStudio revenue event in Q1 2025. The company is executing a disciplined consolidati...
- Q1 2026 revenue came in at $2.7 million, representing a 20% year-over-year decline primarily driven by a one-time CreateStudio revenue event in Q1 2025. On a run-rate basis, revenue remained flat compared to Q4 2025.
- Gross margins held steady at 80.7%, providing a stable foundation despite the top-line contraction. Gross profit decreased 22% year-over-year to $2.2 million.
- The company closed an additional $2.3 million tranche of convertible debt in February as part of its $11 million facility, while also raising $3.3 million in equity to strengthen the balance sheet.
- +9 more takeaways
Lument Finance Trust Q1 2026 Earnings Call - Capital Deployment Stalls as REO Resolution Drives Book Value Decline
Lument Finance Trust reported a modest GAAP net loss of $0.02 per share in Q1 2026, driven by $1.3 million in unrealized impairments on REO assets and a $1.2 million loss on debt extinguishment. Distr...
- GAAP net loss of $0.02 per share, distributable earnings of $0.02 per share; dividend held at $0.04.
- Net interest income rose to $5.7 million, up from $5.4 million in Q4, aided by lower cost of funds.
- Weighted average coupon on the loan portfolio declined to 709 basis points from 717 basis points.
- +7 more takeaways
Starwood Property Trust Q1 2026 Earnings Call - Record $31.7B Investment Base Masks Short-Term Dilution
Starwood Property Trust reported Q1 2026 distributable earnings of $0.39 per share, a figure dragged down by cash balances, REO resolutions, and the ramp-up of its newly acquired net lease platform. A...
- Q1 2026 distributable earnings came in at $0.39 per share, but adjusted for cash drag, REO resolutions, and net lease dilution, underlying earnings power would have been $0.47 per share.
- Total undepreciated assets hit a record $31.7 billion, driven by $2.5 billion in capital deployed during the quarter, with another $1.5 billion deployed post-quarter.
- Commercial Lending portfolio grew to $16.7 billion, with risk ratings improving to a weighted average of 2.9, while non-accrual and REO balances continued to decline.
- +7 more takeaways
Mount Logan Capital Q1 2026 Earnings Call - Recurring Earnings Surge and Strategic M&A Accelerate
Mount Logan Capital reported a sharp improvement in core earnings quality during Q1 2026, with segment income rising 41% year-over-year to $3.3 million. The company successfully pivoted away from lega...
- Segment income surged 41% year-over-year to $3.3 million, driven by a return to positive spread-related earnings of $2 million and improved fee-related earnings of $1.2 million.
- Management announced a definitive agreement to acquire Yieldstreet’s Alternative Income Fund, a move expected to nearly double SOFIX’s net assets and add $2.8 million in annual recurring fee income.
- The insurance investment portfolio yield improved to 6.8% (7.5% excluding funds withheld), reflecting full deployment and a strategic rotation into higher-yielding assets.
- +7 more takeaways
NeoVolta Q3 Fiscal 2026 Earnings Call - First C&I Order Secured as Georgia Manufacturing Ramps
NeoVolta is pivoting from a residential storage provider to a vertically integrated energy platform, with its Georgia manufacturing joint venture on track for production by Q3 calendar year. The compa...
- NeoVolta appointed Jing Nealis as new CFO effective May 18, bringing 20 years of energy transition and manufacturing experience to lead the company through its scaling phase.
- Steve Bond transitioned from CFO to Executive Vice President and President of NeoVolta Power LLC, overseeing the Georgia manufacturing facility’s production ramp.
- Georgia manufacturing equipment has begun arriving on site, with installation targeted for June and initial production ramping in Q3 calendar year.
- +13 more takeaways
NEXGEL Q1 2026 Earnings Call - BioNX Acquisition Tripling Revenue Pro Forma, Legacy Business Stalls
NEXGEL reported a flat Q1 2026 as legacy consumer brands like Silly George underperformed, offset by modest gains in contract manufacturing and MEDAGEL. The company’s strategic pivot rests entirely on...
- Q1 2026 revenue came in at $2.65 million, essentially flat year-over-year despite a strong prior period, highlighting a structural slowdown in the legacy consumer business.
- The core catalyst for NEXGEL is the mid-April acquisition of BioNX Surgical, which adds six commercial-stage regenerative biomaterial products with established reimbursement pathways across 500 U.S. hospitals.
- Management projects the acquisition will immediately triple annual revenue to approximately $35 million on a pro forma basis and be accretive to profitability upon closing.
- +9 more takeaways
DeFi Technologies Q1 2026 Earnings Call - Profitable Amid Crypto Downturn, UCITS Push Accelerates
DeFi Technologies reported a resilient Q1 2026, posting CAD 11.2 million in revenue and a positive net income of CAD 4.9 million despite a challenging digital asset environment that pushed AUM down to...
- DeFi Technologies generated CAD 11.2 million in revenue and CAD 4.9 million in positive net income in Q1 2026, proving operational resilience during a crypto downturn.
- Average AUM stood at CAD 533 million, with a quarterly low of CAD 427 million, driven by broader digital asset price declines and a shift toward lower-fee Bitcoin products.
- The company maintains a fortress balance sheet with over CAD 100 million in combined cash and stablecoins, plus a CAD 47.3 million positive working capital position.
- +7 more takeaways
Credicorp Ltd Q1 2026 Earnings Call - Record ROE and Yape's Accelerating Monetization Drive Growth
Credicorp reported a record first-quarter 2026, delivering a 21.1% return on equity and net income that surpassed expectations. The bank's decoupling strategy is gaining traction, with its innovation ...
- Credicorp delivered a record ROE of 21.1% in Q1 2026, driven by strong loan growth, improved asset quality, and diversified revenue streams.
- The innovation portfolio contributed 9% of risk-adjusted revenues, with Yape already accounting for 8% of the group's risk-adjusted income.
- Loan growth accelerated to 8.2% year-over-year, with retail and wholesale segments both posting robust expansion in Peru.
- +7 more takeaways
RBC Bearings Q4 FY2026 Earnings Call - A&D Surges 41% as Submarine and Missile Demand Reshapes Defense Portfolio
RBC Bearings closed fiscal 2026 on a high note, delivering a record year fueled by an 18.3% year-over-year sales increase to $518 million in the fourth quarter. The aerospace and defense segment was t...
- RBC Bearings delivered record Q4 FY2026 results, with net sales rising 18.3% year-over-year to $518 million, driven by exceptional momentum in the aerospace and defense (A&D) segment and steady industrial growth.
- A&D revenue surged 41.2% year-over-year, with a backlog now standing at approximately $2.3 billion, reflecting robust demand across defense, space, and commercial aircraft markets.
- Submarine programs are a primary growth driver, with the company actively adding machinery and floor space to support the accelerating ramp of Virginia and Columbia class programs, expecting to double revenue in this sector over 24-36 months.
- +7 more takeaways